Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detecting ALK, ROS1, and RET fusions and the METΔex14 splicing variant in liquid biopsies of non-small-cell lung cancer patients using RNA-based techniques.
Giménez-Capitán A, Sánchez-Herrero E, Robado de Lope L, Aguilar-Hernández A, Sullivan I, Calvo V, Moya-Horno I, Viteri S, Cabrera C, Aguado C, Armiger N, Valarezo J, Mayo-de-Las-Casas C, Reguart N, Rosell R, Provencio M, Romero A, Molina-Vila MA. Giménez-Capitán A, et al. Among authors: viteri s. Mol Oncol. 2023 Sep;17(9):1884-1897. doi: 10.1002/1878-0261.13468. Epub 2023 Jun 6. Mol Oncol. 2023. PMID: 37243883 Free PMC article.
Evaluation of multiple serum markers in advanced melanoma.
Díaz-Lagares A, Alegre E, Arroyo A, González-Cao M, Zudaire ME, Viteri S, Martín-Algarra S, González A. Díaz-Lagares A, et al. Among authors: viteri s. Tumour Biol. 2011 Dec;32(6):1155-61. doi: 10.1007/s13277-011-0218-x. Epub 2011 Aug 20. Tumour Biol. 2011. PMID: 21858537
Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.
Nieto Y, Aldaz A, Rifón J, Pérez-Calvo J, Zafra A, Zufia L, Viúdez A, Viteri S, Aramendía JM, Aristu J, Centeno C, Moreno M, Sayar O, Hernández M. Nieto Y, et al. Among authors: viteri s. Biol Blood Marrow Transplant. 2007 Nov;13(11):1324-37. doi: 10.1016/j.bbmt.2007.07.008. Epub 2007 Sep 7. Biol Blood Marrow Transplant. 2007. PMID: 17950919 Free article. Clinical Trial.
Predictive biomarkers in the management of EGFR mutant lung cancer.
Rosell R, Moran T, Cardenal F, Porta R, Viteri S, Molina MA, Benlloch S, Taron M. Rosell R, et al. Among authors: viteri s. Ann N Y Acad Sci. 2010 Oct;1210:45-52. doi: 10.1111/j.1749-6632.2010.05775.x. Ann N Y Acad Sci. 2010. PMID: 20973798
Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.
Simonetti S, Molina MA, Queralt C, de Aguirre I, Mayo C, Bertran-Alamillo J, Sanchez JJ, Gonzalez-Larriba JL, Jimenez U, Isla D, Moran T, Viteri S, Camps C, Garcia-Campelo R, Massuti B, Benlloch S, Ramon y Cajal S, Taron M, Rosell R. Simonetti S, et al. Among authors: viteri s. J Transl Med. 2010 Dec 18;8:135. doi: 10.1186/1479-5876-8-135. J Transl Med. 2010. PMID: 21167064 Free PMC article.
145 results